Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
inDEX: Dexmedetomidine for NIV Tolerance in Acute Respiratory Failure
NCT04878510Phase 3Completed
- Sponsor
- St. Joseph's Healthcare Hamilton
- Start
- Mar 2022
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of dexmedetomidine in Respiratory Insufficiency (RI), sponsored by St. Joseph's Healthcare Hamilton. Started Mar 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Respiratory Insufficiency (RI)
Beyond the preview
Go deeper on NCT04878510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04878510.